期刊文献+

5-HT_(1A)受体激动和5-HT重摄取抑制双靶标新药YL-0919在小鼠体内的组织分布 被引量:1

Tissue distribution of YL-0919,a novel dual-acting antidepressant with 5-HT_(1A) receptor agonist and serotonin reuptake inhibitor in mice
原文传递
导出
摘要 目的研究5-HT1A受体激动和5-HT重摄取抑制双靶标新药YL-0919在小鼠体内的组织分布特征。方法 15只雄性昆明小鼠随机分为3组,单剂量YL-0919(6 mg/kg)灌胃后,分别于2,5,60 min摘眼球取血,处死后解剖取组织。采用液相色谱串联质谱法测定YL-0919浓度。结果小鼠YL-0919灌胃后2 min即在小肠、胃和肝达到最高值,其他组织在给药后5 min浓度达到最高值,浓度由高到低依次为:小肠>胃>肝脏>脂肪>肾脏>肺脏>心脏>脾脏>血>脑>肌肉>睾丸,60 min后各组织的药物浓度均降至较低水平。结论 YL-0919在小鼠体内的吸收和分布较快,药物入血后很快分布到体内各个组织中;药物在组织中的消除也较快,没有组织蓄积现象。 Objective To investigate the tissue distribution of YL-0919,a novel dual-acting antidepressant with 5-HT1A receptor agonist and serotonin reuptake inhibitor in mice.Methods Fifteen male Kunming mice were randomly divided into 3 groups.The samples of plasma and tissues were collected and YL-0919 was determined 2,5 and 60 min after oral administration of 6 mg·kg-1.LC-MS/MS method was established to determine YL-0919 in the tissues of mice.Results YL-0919 was orally administered to mice and the concentration of drugs reached the peak in the intestine,stomach and liver after 2 minutes and in other tissues after 5 minutes,respectively.The organs were listed in the order of the concentration of YL-0919:intestine,stomach,liver,fat,kidney,lung,heart,spleen,plasma,brain,muscle and testis.Concentration of YL-0919 in the tissues decreased to a very low level after 60 minutes.Conclusion YL-0919 can be quickly absorbed,distributed and eliminated after oral administration in mice and no concentration accumulation is observed in the tissues.
出处 《军事医学》 CAS CSCD 北大核心 2012年第2期111-114,共4页 Military Medical Sciences
基金 "国家重大新药创制"科技重大专项资助项目(2009ZX09301-002 2009ZX09304-004)
关键词 抗抑郁药 YL-0919 组织分布 液相色谱串联质谱法 药代动力学 antidepressive agents YL-0919 tissue distribution LC-MS/MS pharmacokinetics
  • 相关文献

参考文献2

二级参考文献33

  • 1张有志,李云峰,陈爽,赵楠,刘艳芹.吲哚洛尔增强帕罗西汀对小鼠的抗抑郁作用[J].军事医学科学院院刊,2006,30(6):596-597. 被引量:3
  • 2World Health Organization.The World Health Report 2001 Mental Health:new understanding,new hope[R].Geneva:WHO,2001.
  • 3Adell A,Castro E,Celada P,et al.Strategies for producing faster acting antidepressants[J].Drug Discov Today,2005,10(8):578-585.
  • 4Stassen HH,Angst J,Hell D,et al.Is there a common resilience mechanism underlying antidepressant drug response?Evidence from 2848 potients[J].J Clin Psychiatry,2007,68(8):1195-1205.
  • 5Savitz J,Lucki I,Drevets WC.5-HT(IA)receptor function in major depressive disorder[J].Prog Neurobiol,2009,88(1):17-31.
  • 6Artigas F,Celada P,Laruelle M,et al.How does pindolol improve antidepressant action?[J].Trends Pharmacol Sci,2001,22(5):224-228.
  • 7Steru L,Chermat R,Thierry B,et al.The tail suspension test:a new method for screening antidepressants in mice[J].Psychopharmacology(Berl),1985,85(3):367-370.
  • 8Porsolt RD,Bertin A,Jalfre M.Behavioural despair in mice:a primary screening test for antidepressants[J].Arch Int Pharmacodyn Ther,1977,229(2):327-336.
  • 9Ferguson SM,Brodkin JD,Lloyd GK,et al.Antidepressantlike effects of the subtype-selective nivotinic acetylcholine receptor agonist,SIB-1508Y,in the learned helplessness rat model of depression[J].Psychopharmacology(Berl),2000,152(3):295-303.
  • 10Martin P,Soubrie P,Simon P.Shuttle-box deficits induced by inescapable shocks in rats:reversal by the beta-adrenoceptor stimulants cleubuterol and salbutamol[J].Pharmacol Biochem Behav,1986,24(2):177-181.

共引文献8

同被引文献9

  • 1Xie XY, Wang R, Shi YP. Chemical constituents from the fruits of Comus officinalis [ J]. Biochem Systemat Ecol,2012,45 ( 12 ) : 120 - 123.
  • 2Wang W, Sun FL, An Y, et al. Morroniside protects human neuroblastoma SH-SY5Y cells against hydrogen peroxide-induced eytotoxicity [ J]. Eur J Pharmaco1,2009,613 ( 1 - 3 ) : 19 - 23.
  • 3Wang W, Huang WT, Li L, et al. Morroniside prevents perox- ide-induced apoptosis by induction of endogenous glutathione in human neuroblastoma cells [ J ]. Cell Mol Neurobiol, 2008,28 (2) : 293 -305.
  • 4Wang W, Xu JD, Li L, et al. Neuroprotective effect of morroni- side on focal cerebral ischemia in rats[ J]. Brain Res Bull, 2010, 83(5) : 196 -201.
  • 5Li XN, Wang Q, Zhang XW, et al. HPLC study of pharmacoki- netics and tissue distribution of morroniside in rats [ J ]. J Pharm Biomed Anal, 2007,45 (2) :349 - 355.
  • 6“化学药物非临床药代动力学研究技术指导原则”(GPT5-1)课题研究组.化学药物非临床药代动力学研究技术指导原则[EB/OL]. http: //www. sda. gov. cn/gsz05106/15, pdf,2005 -03.
  • 7李敬来,王晓英,乔建忠,张振清.左旋苯环壬酯在小鼠体内的组织分布研究[J].解放军药学学报,2011,27(1):27-29. 被引量:1
  • 8刘萍霞,刘频健,庄笑梅,王娟,张玉杰,张振清,阮金秀.抗肿瘤化合物MC002的活性代谢产物雷公藤内酯醇在大鼠体内药代动力学与组织分布[J].中国药理学与毒理学杂志,2011,25(2):206-210. 被引量:10
  • 9张兰桐,任雷鸣,温进坤.山茱萸注射液中马钱素与莫诺苷的药代动力学研究[J].中国中药杂志,2003,28(6):509-512. 被引量:5

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部